Skip to main content
Top
Published in: Modern Rheumatology 6/2013

01-11-2013 | Original Article

Subclinical cardiovascular target organ damage manifestations of ankylosing spondylitis in young adult patients

Authors: Suleyman Ercan, Fatih Goktepe, Bunyamin Kisacik, Yavuz Pehlivan, Ahmet Mesut Onat, Fethi Yavuz, Hayri Alici, Vedat Davutoğlu

Published in: Modern Rheumatology | Issue 6/2013

Login to get access

Abstract

Aim

Although it is known that ankylosing spondylitis (AS) is associated with cardiovascular complications, the extent of these complications has not been clearly demonstrated in young adult patients. We have therefore investigated myocardial diastolic functions, carotid intima-media thickness (CIMT), and aortic elastic properties of young adult patients diagnosed with AS.

Method

Sixty-six AS patients and 21 age/gender-matched healthy subjects were enrolled in the study. Spectral and tissue Doppler echocardiography, CIMT, aortic strain and distensibility, and serum B-type natriuretic peptide values were compared with disease activity indexes of AS, including the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the role of other variables, such as anti-tumor necrosis factor-alpha (anti-TNF-α) treatment, lipid parameters, erythrocyte sedimentation rate, and C-reactive protein.

Results

Both mitral early diastolic flow speed (mE) and late diastolic flow speed (mA) scores were lower among patients than among the control subjects (p = 0.015 and p = 0.035, respectively). The Em ratio of the patients was remarkably lower than that of the control subjects (p = 0.044). BASDAI scores of >4 were used to identify patients with more active disease. The mA and mE/mA ratios were significantly different between patients with a BASDAI score of >4 and those with a BASDAI score of <4 (p = 0.026 and p = 0.021, respectively). While aortic elasticity were not significantly different between the groups, AS patients treated with anti-TNF-α had significantly improved aortic strain and distensibility values (p = 0.022 and p = 0.014, respectively) compared to those treated with non-steroidal anti-inflammatory drugs (NSAIDs).

Conclusion

Myocardial diastolic functions were significantly deteriorated in the AS patients, and disease activity and myocardial diastolic functions were associated. An interesting finding was that patients receiving anti-TNF-α had better aortic elasticity than those treated with NSAIDs.
Literature
1.
go back to reference Momeni M, Taylor N, Tehrani M. Cardiopulmonary manifestations of ankylosing spondylitis. Int J Rheumatol. 2011;2011:728471.PubMed Momeni M, Taylor N, Tehrani M. Cardiopulmonary manifestations of ankylosing spondylitis. Int J Rheumatol. 2011;2011:728471.PubMed
2.
go back to reference Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32.PubMedCrossRef Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis. 1992;51:227–32.PubMedCrossRef
3.
4.
go back to reference Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol. 2002;21:129–34.PubMedCrossRef Yildirir A, Aksoyek S, Calguneri M, Oto A, Kes S. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol. 2002;21:129–34.PubMedCrossRef
5.
go back to reference Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.PubMedCrossRef Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.PubMedCrossRef
6.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286–91.PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286–91.PubMed
7.
go back to reference Lacombe F, Dart A, Dewar E, Jennings G, Cameron J, Laufer E. Arterial elastic properties in man: a comparison of echo-Doppler indices of aortic stiffness. Eur Heart J. 1992;13:1040–5.PubMed Lacombe F, Dart A, Dewar E, Jennings G, Cameron J, Laufer E. Arterial elastic properties in man: a comparison of echo-Doppler indices of aortic stiffness. Eur Heart J. 1992;13:1040–5.PubMed
8.
go back to reference Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility in post-stenotic aortic dilatation: the effect of co-existing coronary artery disease. J Cardiol. 1988;18:189–95.PubMed Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility in post-stenotic aortic dilatation: the effect of co-existing coronary artery disease. J Cardiol. 1988;18:189–95.PubMed
9.
go back to reference Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol. 2005;25:24–9.PubMedCrossRef Brunner F, Kunz A, Weber U, Kissling R. Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population? Clin Rheumatol. 2005;25:24–9.PubMedCrossRef
10.
go back to reference Davutoglu V, Yildirim C, Kucukaslan H, Yuce M, Sari I, Tarakcioglu M, Akcay M, Cakici M, Ceylan N, Al B. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure. Kardiol Pol. 2010;68:771–8.PubMed Davutoglu V, Yildirim C, Kucukaslan H, Yuce M, Sari I, Tarakcioglu M, Akcay M, Cakici M, Ceylan N, Al B. Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure. Kardiol Pol. 2010;68:771–8.PubMed
11.
go back to reference Davutoglu V, Celik A, Aksoy M, Sezen Y, Soydinc S, Gunay N. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail. 2005;7:532–6.PubMedCrossRef Davutoglu V, Celik A, Aksoy M, Sezen Y, Soydinc S, Gunay N. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur J Heart Fail. 2005;7:532–6.PubMedCrossRef
12.
go back to reference Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail. 2008;10:252–9.PubMedCrossRef Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail. 2008;10:252–9.PubMedCrossRef
13.
go back to reference Sakuragi S, Iwasaki J, Tokunaga N, Hiramatsu S, Ohe T. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease. Cardiology. 2005;103:107–12.PubMedCrossRef Sakuragi S, Iwasaki J, Tokunaga N, Hiramatsu S, Ohe T. Aortic stiffness is an independent predictor of left ventricular function in patients with coronary heart disease. Cardiology. 2005;103:107–12.PubMedCrossRef
14.
go back to reference Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, CORD Study Investigators. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6:153–9.PubMedCrossRef Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, CORD Study Investigators. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6:153–9.PubMedCrossRef
15.
go back to reference Sweitzer NK, Shenoy M, Stein JH, Keles S, Palta M, LeCaire T, Mitchell GF. Increases in central aortic impedance precede alterations in arterial stiffness measures in type 1 diabetes. Diabetes Care. 2007;30:2886–91.PubMedCrossRef Sweitzer NK, Shenoy M, Stein JH, Keles S, Palta M, LeCaire T, Mitchell GF. Increases in central aortic impedance precede alterations in arterial stiffness measures in type 1 diabetes. Diabetes Care. 2007;30:2886–91.PubMedCrossRef
16.
go back to reference Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004;90:37–43.PubMedCrossRef Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004;90:37–43.PubMedCrossRef
17.
go back to reference Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke. 2012;43:543–4.PubMedCrossRef Gasecki D, Rojek A, Kwarciany M, Kubach M, Boutouyrie P, Nyka W, Laurent S, Narkiewicz K. Aortic stiffness predicts functional outcome in patients after ischemic stroke. Stroke. 2012;43:543–4.PubMedCrossRef
18.
go back to reference Roldan CA, Joson J, Qualls CR, Sharrar J, Sibbitt WL Jr. Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography. Lupus. 2010;19:1599–605.PubMedCrossRef Roldan CA, Joson J, Qualls CR, Sharrar J, Sibbitt WL Jr. Premature aortic stiffness in systemic lupus erythematosus by transesophageal echocardiography. Lupus. 2010;19:1599–605.PubMedCrossRef
19.
go back to reference Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32:1397–404.PubMedCrossRef Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32:1397–404.PubMedCrossRef
20.
go back to reference Sucu MM, Davutoglu V, Akcay M, Yiğiter R, Al B. Aortic elastic properties of patients with neurocardiogenic syncope. Pacing Clin Electrophysiol. 2009;32:1417–21.PubMedCrossRef Sucu MM, Davutoglu V, Akcay M, Yiğiter R, Al B. Aortic elastic properties of patients with neurocardiogenic syncope. Pacing Clin Electrophysiol. 2009;32:1417–21.PubMedCrossRef
21.
go back to reference Pannier B, London GM. Effects of aortic stiffness abnormalities on the heart. Semin Dial. 2011;24:282–5.PubMedCrossRef Pannier B, London GM. Effects of aortic stiffness abnormalities on the heart. Semin Dial. 2011;24:282–5.PubMedCrossRef
22.
go back to reference Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38:723–9.PubMedCrossRef Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S. Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol. 2011;38:723–9.PubMedCrossRef
23.
go back to reference Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int. 2010;30:1411–6.PubMedCrossRef Azevedo VF, Pecoits-Filho R. Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis. Rheumatol Int. 2010;30:1411–6.PubMedCrossRef
24.
go back to reference Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford). 2008;47:1203–7.CrossRef Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford). 2008;47:1203–7.CrossRef
25.
go back to reference Erre GL, Sanna P, Zinellu A, Ponchietti A, Fenu P, Sotgia S, Carru C, Ganau A, Passiu G. Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol. 2011;30:21–7.PubMedCrossRef Erre GL, Sanna P, Zinellu A, Ponchietti A, Fenu P, Sotgia S, Carru C, Ganau A, Passiu G. Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol. 2011;30:21–7.PubMedCrossRef
26.
go back to reference Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal. 2009;11:1913–28.PubMedCrossRef Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal. 2009;11:1913–28.PubMedCrossRef
27.
go back to reference Wofford J, Kahl F, Howard G, McKinney W, Toole J, Crouse JI. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786–94.PubMedCrossRef Wofford J, Kahl F, Howard G, McKinney W, Toole J, Crouse JI. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 1991;11:1786–94.PubMedCrossRef
28.
go back to reference Mathıeu S, Gossec L, Dougados M, Soubrıer M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:557–63.CrossRef Mathıeu S, Gossec L, Dougados M, Soubrıer M. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:557–63.CrossRef
29.
go back to reference Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, Yucel E, Muderrisoglu H. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008;196:306–12.PubMedCrossRef Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, Yucel E, Muderrisoglu H. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis. 2008;196:306–12.PubMedCrossRef
30.
go back to reference Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford). 2006;45:283–6.CrossRef Sari I, Okan T, Akar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford). 2006;45:283–6.CrossRef
31.
go back to reference Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4.PubMedCrossRef Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol. 2007;26:710–4.PubMedCrossRef
32.
go back to reference Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine. 2008;75:548–53.PubMedCrossRef Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK. No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine. 2008;75:548–53.PubMedCrossRef
Metadata
Title
Subclinical cardiovascular target organ damage manifestations of ankylosing spondylitis in young adult patients
Authors
Suleyman Ercan
Fatih Goktepe
Bunyamin Kisacik
Yavuz Pehlivan
Ahmet Mesut Onat
Fethi Yavuz
Hayri Alici
Vedat Davutoğlu
Publication date
01-11-2013
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 6/2013
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-012-0791-x

Other articles of this Issue 6/2013

Modern Rheumatology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine